Nolla Health is preparing to launch a pilot program in Utah that could mark the first time an AI system prescribes medication without direct doctor oversight. The program targets patients with mild-to-moderate acne, using photo analysis and medical history to generate a severity score and recommend one of eight approved treatments. Initially, physicians will review prescriptions before they are issued, but the plan gradually removes that requirement as the program scales.
The pilot operates in three stages. For the first 100 patients, two physicians must approve each AI-generated prescription. For up to 500 patients, doctors review prescriptions after they are issued. In the final phase, Nolla Health plans to bypass prior human review entirely. The service costs about $4.99 per month, with medications running roughly $50 per month. Utah regulators have responded by requiring third-party audits of Nolla's claims, part of a broader push to expand AI in healthcare.
Meanwhile, AI is making waves in other sectors. A Menlo Ventures study found that AI agents like OpenAI Dots, Grok bots, Meta Muse, and OpenClaw Instinct are expected to drive $100 billion in online sales within 12 months. Among AI agent users, 92% pay for the technology and 63% use it daily, signaling a rapid shift in how consumers shop online.
Security concerns are mounting alongside the growth. Gartner expects spending on AI security to reach $2.8 billion in 2026 and $4.8 billion by 2027. Companies including OpenAI, Anthropic, Google, Microsoft, CrowdStrike, Okta, and Fortinet have called for stronger AI defenses. Experts recommend building a full inventory of all AI agents, models, and permissions to reduce risk.
Former FTC Chair Khan criticized a self-regulation charter signed by AI industry leaders, arguing that past efforts at tech self-regulation have failed and that outside rules are needed. The debate over oversight comes as AI spending becomes harder to track. Gartner reports global AI and business analytics spending will hit $1.2 trillion by 2026, up 21% from the previous year, though separating AI from general analytics budgets is increasingly difficult.
On the hardware front, the rise of agentic AI is boosting demand for AMD data center chips, as agents require more complex inference calls per task. NVIDIA shares neared a record high of about $233.95, up 25% this year, with the company worth roughly $5.64 to $5.7 trillion. NVIDIA plans to add $150 billion to its buyback program, and recent AI chip sales reached $96.2 billion, more than double last year.
JPMorgan Chase is marketing a $5 billion leveraged loan for Volta Infrastructure Holdings, offering about an 11% yield. The funds will help build a data center in Norway where Anthropic has already signed a six-year deal for compute space. The loan will finance roughly 36,000 Nvidia GPUs, underscoring the massive infrastructure demands driving AI investment.
Key Takeaways
- Nolla Health launches Utah pilot letting AI prescribe acne treatments, starting with physician oversight and gradually removing it across three stages
- Utah regulators require third-party audits of Nolla Health as the first state to allow AI to replace a doctor's prescribing role
- AI agents like OpenAI Dots, Grok bots, Meta Muse, and OpenClaw Instinct are forecast to drive $100 billion in online sales within 12 months
- Gartner projects AI security spending will reach $2.8 billion in 2026 and $4.8 billion by 2027 as companies rush to secure AI agents
- OpenAI, Anthropic, Google, Microsoft, CrowdStrike, Okta, and Fortinet have called for stronger AI defenses amid growing security concerns
- Former FTC Chair Khan dismissed an AI self-regulation charter, arguing that outside rules are needed instead of industry self-policing
- Global AI and business analytics spending will reach $1.2 trillion by 2026, up 21% year-over-year, though tracking AI-specific costs is growing harder
- NVIDIA shares hit about $233.95, up 25% this year, with the company valued at roughly $5.64 to $5.7 trillion and $150 billion added to its buyback program
- JPMorgan markets a $5 billion loan for Volta Infrastructure at an 11% yield to build a Norway data center where Anthropic has a six-year compute deal
- Agentic AI is increasing demand for AMD's Instinct GPUs and EPYC CPUs due to more complex inference requirements per task
Nolla Health launches AI acne prescription pilot in Utah
Nolla Health is launching a pilot program in Utah that uses AI to prescribe acne treatments. For the first 100 patients, two physicians must approve each AI-generated prescription before it is issued. For up to 500 patients, doctors will review prescriptions after they are issued. The program costs $4.99 per month and is available to Utah residents aged 18 and older with mild-to-moderate acne. The AI can currently prescribe eight different skin treatments.
Utah allows AI to prescribe acne medication without a doctor
Nolla Health will start offering AI-generated prescriptions to Utah patients without direct human oversight, marking the first time a state has allowed AI to replace a doctor's prescribing role. Patients scan their face and complete their medical history, then the AI analyzes their skin and generates an acne severity score. The AI recommends medication from a list of eight approved treatments. The pilot targets an estimated 5,500 to 11,000 acne patients in Utah who seek dermatological care each year. The app costs about $5 per month, with medications at about $50 per month.
Utah expands health AI pilots with third-party audits
Utah regulators announced a plan to allow an AI product to evaluate patients for acne treatment and write new drug prescriptions without prior human review. Nolla Health will launch the AI-powered service in Utah to assess patients for mild-to-moderate acne using structured intake and photo analysis. In early stages, a licensed clinician will review and sign off on AI decisions. The state will require third-party audits of company claims in response to critics. The program is part of Utah's broader effort to expand AI in healthcare.
AI startup prescribes acne medication without direct doctor oversight
Nolla Health will launch in Utah, becoming the first company to let AI prescribe acne medication without direct human oversight. Patients scan their face and the AI analyzes their skin, oiliness, and generates an acne severity score. The app then recommends one of eight approved treatments. Prescriptions will be submitted directly to pharmacies, bypassing laws requiring licensed professionals to prescribe. The program will operate in three stages, gradually reducing physician review. Chief Executive Luis Wenus says the goal is to eventually expand beyond acne to become an all-in personal doctor driven by AI.
AI agents forecast to drive 100 billion in online sales
AI agents like OpenAI Dots, Grok bots, Meta Muse, and OpenClaw Instinct are expected to drive $100 billion in online sales within 12 months. A Menlo Ventures study found that 41% of participants had tried an AI agent, 24% use one regularly, and 32% let AI act on their behalf without final approval. Among AI agent users, 92% pay for AI and 63% use it daily. Marketers must shift to agent optimization as traditional advertising methods lose effectiveness. AI agents can autonomously purchase products, bypassing traditional marketing funnels.
AI Agents Set to Drive $100B in Holiday Sales
AI agents like OpenAI Dots, Grok bots, Meta Muse, and OpenClaw Instinct are expected to drive $100 billion in sales by next year. These agentic commerce tools will transform digital advertising and marketing during the holiday season. The shift marks a major change in how consumers shop online.
AI Agent Security Debt Catches Up With Companies
Many companies deployed AI agents quickly without proper security. Gartner expects spending on AI security to reach $2.8 billion in 2026 and $4.8 billion by 2027. Companies like OpenAI, Anthropic, Google, Microsoft, CrowdStrike, Okta, and Fortinet have called for stronger AI defenses. Experts urge teams to build an inventory of all AI agents, models, permissions, and tools to reduce risk.
IDEMIA WebCapture SDK Passes Deepfake Security Test
IDEMIA Public Security's WebCapture SDK passed independent testing by BixeLab against deepfake and biometric fraud attacks. Across 900 attack attempts using methods like face swaps and replay attacks, none successfully bypassed the system. The SDK achieved CEN/TS 18099 Substantial-level validation with a false rejection rate of just 0.67%. The test confirms strong protection against AI-generated identity fraud.
AI Helps Build Smarter Real Estate Sales Pipelines
AI is transforming real estate CRM tools from simple lead trackers into powerful sales assistants. A June 2026 report by EY-Parthenon and CREDAI says GenAI could improve sales velocity in Indian real estate by 30 to 50 percent. AI lets managers ask questions in plain language and see how leads move through the entire sales funnel. It also measures sales activity against actual results like bookings and revenue.
AI Spending Becomes Hard to Track in Budgets
Gartner reports global spending on AI and business analytics will reach $1.2 trillion by 2026, up 21 percent from last year. However, separating AI spending from business analytics spending is becoming very difficult. About 70 percent of organizations use AI to augment human capabilities while 30 percent use it to automate tasks. Data quality remains a challenge, with 60 percent of organizations struggling in this area.
JPMorgan pitches 11% yield on Volta's $5 billion AI loan
JPMorgan Chase is marketing a $5 billion leveraged loan for Volta Infrastructure Holdings. The loan offers about an 11% yield, making it one of the most expensive deals in the risky debt market. The money will help build a data center in Norway. Anthropic has already signed a six-year deal for compute space at the site. The loan will buy about 36,000 Nvidia GPUs.
Former FTC Chair Khan criticizes AI self-regulation charter
Former FTC Chair Khan dismissed a constitution signed by AI leaders to self-police their industry. The document was meant to guide responsible AI development. Khan argued that past efforts at tech self-regulation have failed. The move highlights ongoing concerns about AI industry oversight. Critics say outside rules are needed instead.
Agentic AI drives demand for AMD data center chips
The rise of agentic AI is increasing inference needs for Advanced Micro Devices. Agents require more complex inference calls per task. This drives demand for AMD's Instinct GPUs, EPYC CPUs, and data center tools. Glass Lake Wealth Management noted AMD as a key beneficiary. AI investment remains the main growth engine in the market.
NVIDIA stock nears record high on buyback and AI sales
NVIDIA shares hit about $233.95, up 25% this year. The company is now worth roughly $5.64 to $5.7 trillion. NVIDIA plans to add $150 billion to its share buyback program, bringing the total to $235 billion. Recent AI chip sales reached $96.2 billion, more than double last year. Experts believe the stock could reach $320 to $345 within a year.
Sources
- This startup is issuing AI-generated acne prescriptions
- AI replaces a prescribing doctor for the first time
- Utah plows ahead with more health AI pilots for prescriptions, women’s health
- AI startup prescribes acne medication without a doctor’s direct oversight
- MediaDailyNews: AI Agents Forecast To Drive $100B In Online Sales By Next Year
- AI Agents Forecast To Drive $100B In Sales By Next Year
- Everyone Rushed to Deploy AI Agents. Now the Security Debt Is Coming Due
- IDEMIA Public Security's WebCapture SDK Earns Independent Validation Against Deepfake and Biometric Fraud Attacks
- Beyond Lead Tracking: How is AI Building Smarter Real Estate Sales Pipelines?
- AI Spending Is The Honey Badger Of Budgets
- JPMorgan Dangles 11% Yield on Volta’s $5 Billion AI Loan Sale
- Former FTC Chair Khan dismisses 'constitution' signed by AI leaders to self-police
- How the Rise of Agentic AI Is Scaling Inference Requirements for Advanced Micro Devices (AMD)?
- NVIDIA Stock Hits New High Near $238 After Big Buyback and Strong AI Sales
Comments
Please log in to post a comment.